Recommended Topic Related To:

Aubagio

"Nov. 18, 2012 -- Researchers say they've been able to use nanoparticles to stop multiple sclerosis (MS) in mice that are bred to have the disease.

The particles are about 200 times smaller than the thickness of a human hair. They are "...

Aubagio

INDICATIONS

AUBAGIO® is indicated for the treatment of patients with relapsing forms of multiple sclerosis [see Clinical Studies].

DOSAGE AND ADMINISTRATION

The recommended dose of AUBAGIO is 7 mg or 14 mg orally once daily. AUBAGIO can be taken with or without food.

Monitoring to assess safety
  • Obtain transaminase and bilirubin levels within 6 months before initiation of AUBAGIO therapy. Monitor ALT levels at least monthly for six months after starting AUBAGIO [see WARNINGS AND PRECAUTIONS].
  • Obtain a complete blood cell count (CBC) within 6 months before the initiation of treatment with AUBAGIO. Further monitoring should be based on signs and symptoms of infection [see WARNINGS AND PRECAUTIONS].
  • Prior to initiating AUBAGIO, screen patients for latent tuberculosis infection with a tuberculin skin test [see WARNINGS AND PRECAUTIONS].
  • Check blood pressure before start of AUBAGIO treatment and periodically thereafter [see WARNINGS AND PRECAUTIONS].

HOW SUPPLIED

Dosage Forms And Strengths

AUBAGIO is available as 7 mg and 14 mg tablets.

The 14 mg tablet is a pale blue to pastel blue, pentagonal film-coated tablet with the dose strength, “14” imprinted on one side and engraved with the corporate logo on the other side. Each tablet contains 14 mg of teriflunomide.

The 7 mg tablet is a very light greenish-bluish grey to pale greenish-blue, hexagonal film-coated tablet with dose strength “7” imprinted on one side and engraved with the corporate logo on other side. Each tablet contains 7 mg of teriflunomide.

Storage And Handling

AUBAGIO is available 7 mg and 14 mg tablets.

The 14 mg tablet is pale blue to pastel blue, pentagonal film-coated tablets with imprint on one side dose strength given as number 14 and engraved with corporate logo on the other side.

The 7 mg tablet is very light greenish-bluish grey to pale greenish-blue, hexagonal film-coated tablets with dose strength “7” imprinted on one side and engraved with corporate logo on other side. Each tablet contains 7 mg of teriflunomide.

AUBAGIO 14 mg tablets are supplied as:

NDC 58468-0210-2 Carton of 28 tablets containing 1 wallet composed of 2 folded blister cards of 14 tablets per blister card

NDC 58468-0210-1 Carton of 5 tablets with one blister card with five tablets AUBAGIO 7 mg tablets are supplied as:

NDC 58468-0211-1 Carton of 28 tablets containing 1 wallet composed of 2 folded blister cards of 14 tablets per blister card

NDC 58468-0211-2 Carton of 5 tablets with one blister card with five tablets

Store at 68°F to 77°F (20°C to 25°C) with excursions permitted between 59°F and 86°F (15°C and 30°C).

Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142, A Sanofi Company. September 2012

Last reviewed on RxList: 9/21/2012
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Multiple Sclerosis

Get the latest treatment options.

advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations